H.Con.Res. 342 · 110th Congress
Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
- Stage
- In committee
- Sponsor
- Mike Ross
- Introduced
- 2008-05-06
- Latest action
- 2008-05-07 · Referred to the Subcommittee on Health.
Summary
Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.